336 related articles for article (PubMed ID: 38292487)
1. Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.
Katopodi T; Petanidis S; Anestakis D; Charalampidis C; Chatziprodromidou I; Floros G; Eskitzis P; Zarogoulidis P; Koulouris C; Sevva C; Papadopoulos K; Dagher M; Karakousis VA; Varsamis N; Theodorou V; Mystakidou CM; Vlassopoulos K; Kosmidis S; Katsios NI; Farmakis K; Kosmidis C
Front Immunol; 2023; 14():1325360. PubMed ID: 38292487
[TBL] [Abstract][Full Text] [Related]
2. The cancer metabolic reprogramming and immune response.
Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
[TBL] [Abstract][Full Text] [Related]
3. The Role of Tumor Metabolic Reprogramming in Tumor Immunity.
Zhang X; Song W; Gao Y; Zhang Y; Zhao Y; Hao S; Ni T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139250
[TBL] [Abstract][Full Text] [Related]
4. Manipulating T-cell metabolism to enhance immunotherapy in solid tumor.
Chen C; Wang Z; Ding Y; Qin Y
Front Immunol; 2022; 13():1090429. PubMed ID: 36618408
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
6. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
Chen L; Huang L; Gu Y; Cang W; Sun P; Xiang Y
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233246
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming in the tumor microenvironment of liver cancer.
Lin J; Rao D; Zhang M; Gao Q
J Hematol Oncol; 2024 Jan; 17(1):6. PubMed ID: 38297372
[TBL] [Abstract][Full Text] [Related]
8. Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.
Wei F; Wang D; Wei J; Tang N; Tang L; Xiong F; Guo C; Zhou M; Li X; Li G; Xiong W; Zhang S; Zeng Z
Cell Mol Life Sci; 2021 Jan; 78(1):173-193. PubMed ID: 32654036
[TBL] [Abstract][Full Text] [Related]
9. Lactate-related metabolic reprogramming and immune regulation in colorectal cancer.
Sun Q; Wu J; Zhu G; Li T; Zhu X; Ni B; Xu B; Ma X; Li J
Front Endocrinol (Lausanne); 2022; 13():1089918. PubMed ID: 36778600
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
11. Functions and mechanisms of lactylation in carcinogenesis and immunosuppression.
Su J; Zheng Z; Bian C; Chang S; Bao J; Yu H; Xin Y; Jiang X
Front Immunol; 2023; 14():1253064. PubMed ID: 37646027
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
13. Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment.
Wei J; Hu M; Du H
Front Immunol; 2022; 13():845923. PubMed ID: 35281061
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
[TBL] [Abstract][Full Text] [Related]
15. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
16. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy.
Zhou Y; Yuan J; Xu K; Li S; Liu Y
ACS Nano; 2024 Jan; 18(3):1846-1864. PubMed ID: 38180952
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
[TBL] [Abstract][Full Text] [Related]
19. Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy.
Miao L; Lu C; Zhang B; Li H; Zhao X; Chen H; Liu Y; Cui X
J Transl Med; 2024 Mar; 22(1):229. PubMed ID: 38433193
[TBL] [Abstract][Full Text] [Related]
20. Insights into the Effect of Catalytic Intratumoral Lactate Depletion on Metabolic Reprogramming and Immune Activation for Antitumoral Activity.
Zhao J; Tian Z; Zhao S; Feng D; Guo Z; Wen L; Zhu Y; Xu F; Zhu J; Ma S; Hu J; Jiang T; Qu Y; Chen D; Liu L
Adv Sci (Weinh); 2023 Feb; 10(4):e2204808. PubMed ID: 36479819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]